SARS-CoV-2 mRNA Vaccinations Fail to Elicit Humoral and Cellular Immune Responses in Patients With MS Receiving Fingolimod
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Neurology, Neurosurgery, and Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod
J. Neurol. Neurosurg. Psychiatr. 2022 Sep 01;93(9)960-971, L Meyer-Arndt, J Braun, F Fauchere, K Vanshylla, L Loyal, L Henze, B Kruse, M Dingeldey, K Jürchott, M Mangold, A Maraj, A Braginets, C Böttcher, A Nitsche, K de la Rosa, C Ratswohl, B Sawitzki, P Holenya, U Reimer, LE Sander, F Klein, F Paul, J Bellmann-Strobl, A Thiel, C Giesecke-ThielFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.